vs

Cytek Biosciences, Inc.(CTKB)与Velocity Financial, Inc.(VEL)财务数据对比。点击上方公司名可切换其他公司

Cytek Biosciences, Inc.的季度营收约是Velocity Financial, Inc.的1.2倍($62.1M vs $51.6M),Velocity Financial, Inc.净利率更高(67.3% vs -70.9%,领先138.3%),Velocity Financial, Inc.同比增速更快(32.8% vs 8.1%),Velocity Financial, Inc.自由现金流更多($17.9M vs $-1.8M),过去两年Velocity Financial, Inc.的营收复合增速更高(32.3% vs 17.7%)

Cytek Biosciences主营高性能流式细胞分析系统、配套试剂及分析软件的研发、生产与商业化,产品服务覆盖生命科学研究、临床诊断、生物制药开发等领域,客户遍及全球多个主要地区。

Velocity Financial, Inc.是一家总部位于美国的房地产金融企业,主要面向住宅投资物业提供专业化抵押贷款解决方案,与全美独立抵押贷款经纪人合作,为房地产投资者提供定制化的短期过桥贷款及长期租赁物业融资产品。

CTKB vs VEL — 直观对比

营收规模更大
CTKB
CTKB
是对方的1.2倍
CTKB
$62.1M
$51.6M
VEL
营收增速更快
VEL
VEL
高出24.7%
VEL
32.8%
8.1%
CTKB
净利率更高
VEL
VEL
高出138.3%
VEL
67.3%
-70.9%
CTKB
自由现金流更多
VEL
VEL
多$19.7M
VEL
$17.9M
$-1.8M
CTKB
两年增速更快
VEL
VEL
近两年复合增速
VEL
32.3%
17.7%
CTKB

损益表 — Q4 FY2025 vs Q4 FY2025

指标
CTKB
CTKB
VEL
VEL
营收
$62.1M
$51.6M
净利润
$-44.1M
$34.8M
毛利率
52.9%
营业利润率
-9.0%
97.0%
净利率
-70.9%
67.3%
营收同比
8.1%
32.8%
净利润同比
-557.1%
67.0%
每股收益(稀释后)
$0.90

绿色 = 该指标领先。财年不对齐时期间可能不同

8季度营收与利润趋势

并排季度历史对比,按日历期对齐,财年错位的公司也能正确匹配

营收
CTKB
CTKB
VEL
VEL
Q4 25
$62.1M
$51.6M
Q3 25
$52.3M
$49.1M
Q2 25
$45.6M
$47.6M
Q1 25
$41.5M
$37.5M
Q4 24
$57.5M
$38.9M
Q3 24
$51.5M
$35.1M
Q2 24
$46.6M
$32.4M
Q1 24
$44.9M
$29.5M
净利润
CTKB
CTKB
VEL
VEL
Q4 25
$-44.1M
$34.8M
Q3 25
$-5.5M
$25.4M
Q2 25
$-5.6M
$26.0M
Q1 25
$-11.4M
$18.9M
Q4 24
$9.6M
$20.8M
Q3 24
$941.0K
$15.8M
Q2 24
$-10.4M
$14.8M
Q1 24
$-6.2M
$17.3M
毛利率
CTKB
CTKB
VEL
VEL
Q4 25
52.9%
Q3 25
52.7%
Q2 25
52.3%
Q1 25
48.6%
Q4 24
58.5%
Q3 24
56.3%
Q2 24
54.6%
Q1 24
51.3%
营业利润率
CTKB
CTKB
VEL
VEL
Q4 25
-9.0%
97.0%
Q3 25
-17.6%
72.1%
Q2 25
-23.3%
71.3%
Q1 25
-36.1%
71.7%
Q4 24
5.2%
82.5%
Q3 24
-8.2%
60.6%
Q2 24
-18.3%
61.3%
Q1 24
-23.9%
78.8%
净利率
CTKB
CTKB
VEL
VEL
Q4 25
-70.9%
67.3%
Q3 25
-10.5%
51.7%
Q2 25
-12.2%
54.6%
Q1 25
-27.5%
50.4%
Q4 24
16.8%
53.5%
Q3 24
1.8%
45.1%
Q2 24
-22.4%
45.6%
Q1 24
-13.8%
58.5%
每股收益(稀释后)
CTKB
CTKB
VEL
VEL
Q4 25
$0.90
Q3 25
$0.65
Q2 25
$0.69
Q1 25
$0.51
Q4 24
$0.56
Q3 24
$0.44
Q2 24
$0.42
Q1 24
$0.49

资产负债表与财务实力

最新季度各公司的流动性、杠杆与账面价值一览

指标
CTKB
CTKB
VEL
VEL
现金及短期投资手头流动性
$90.9M
$92.1M
总债务越低越好
股东权益账面价值
$341.7M
$672.5M
总资产
$461.5M
$7.4B
负债/权益比越低杠杆越低

8季度趋势,按日历期对齐

现金及短期投资
CTKB
CTKB
VEL
VEL
Q4 25
$90.9M
$92.1M
Q3 25
$93.3M
$99.0M
Q2 25
$75.5M
$79.6M
Q1 25
$95.3M
$51.7M
Q4 24
$98.7M
$49.9M
Q3 24
$162.3M
$44.1M
Q2 24
$177.9M
$47.4M
Q1 24
$168.8M
$34.8M
股东权益
CTKB
CTKB
VEL
VEL
Q4 25
$341.7M
$672.5M
Q3 25
$378.6M
$634.3M
Q2 25
$377.6M
$597.9M
Q1 25
$379.6M
$563.2M
Q4 24
$395.7M
$516.9M
Q3 24
$385.5M
$484.6M
Q2 24
$389.1M
$471.3M
Q1 24
$392.6M
$452.9M
总资产
CTKB
CTKB
VEL
VEL
Q4 25
$461.5M
$7.4B
Q3 25
$494.9M
$7.0B
Q2 25
$493.3M
$6.5B
Q1 25
$482.6M
$6.0B
Q4 24
$499.5M
$5.5B
Q3 24
$491.2M
$5.2B
Q2 24
$483.7M
$4.9B
Q1 24
$492.1M
$4.6B

现金流与资本效率

扣除再投资后实际产生的现金。现金流比净利润更难造假

指标
CTKB
CTKB
VEL
VEL
经营现金流最新季度
$-771.0K
$18.2M
自由现金流经营现金流 - 资本支出
$-1.8M
$17.9M
自由现金流率自由现金流/营收
-2.9%
34.6%
资本支出强度资本支出/营收
1.6%
0.5%
现金转化率经营现金流/净利润
0.52×
过去12个月自由现金流最近4个季度
$-8.8M
$40.3M

8季度趋势,按日历期对齐

经营现金流
CTKB
CTKB
VEL
VEL
Q4 25
$-771.0K
$18.2M
Q3 25
$-3.9M
$11.5M
Q2 25
$108.0K
$7.7M
Q1 25
$-125.0K
$3.5M
Q4 24
$2.0M
$37.8M
Q3 24
$13.2M
$-17.6M
Q2 24
$6.2M
$11.5M
Q1 24
$4.0M
$10.6M
自由现金流
CTKB
CTKB
VEL
VEL
Q4 25
$-1.8M
$17.9M
Q3 25
$-4.6M
$11.4M
Q2 25
$-1.5M
$7.6M
Q1 25
$-974.0K
$3.5M
Q4 24
$1.1M
$37.5M
Q3 24
$12.2M
$-17.6M
Q2 24
$5.2M
$11.4M
Q1 24
$3.4M
$10.5M
自由现金流率
CTKB
CTKB
VEL
VEL
Q4 25
-2.9%
34.6%
Q3 25
-8.7%
23.2%
Q2 25
-3.2%
15.9%
Q1 25
-2.3%
9.2%
Q4 24
1.9%
96.4%
Q3 24
23.7%
-50.3%
Q2 24
11.0%
35.1%
Q1 24
7.6%
35.8%
资本支出强度
CTKB
CTKB
VEL
VEL
Q4 25
1.6%
0.5%
Q3 25
1.3%
0.1%
Q2 25
3.5%
0.2%
Q1 25
2.0%
0.2%
Q4 24
1.6%
0.7%
Q3 24
2.0%
0.2%
Q2 24
2.3%
0.3%
Q1 24
1.3%
0.1%
现金转化率
CTKB
CTKB
VEL
VEL
Q4 25
0.52×
Q3 25
0.45×
Q2 25
0.29×
Q1 25
0.19×
Q4 24
0.21×
1.81×
Q3 24
14.05×
-1.11×
Q2 24
0.78×
Q1 24
0.61×

财务流量对比

营收 → 毛利润 → 营业利润 → 净利润流向图

业务分部营收拆解

CTKB
CTKB

Products$46.6M75%
Services$15.5M25%

VEL
VEL

Related Party$19.3M37%
Nonrelated Party$16.9M33%
Other$15.4M30%

相关对比